Korea Revises Rules To Curb Rebate Activities, Improve Ethics
Executive Summary
South Korea continues efforts to root out illegal rebate payments for drugs and to step up the pharma industry's ethics and social responsibility by revising relevant rules, but in a way that doesn't harm patients' health.